234 related articles for article (PubMed ID: 25972448)
1. The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray.
Deliu E; Sperow M; Console-Bram L; Carter RL; Tilley DG; Kalamarides DJ; Kirby LG; Brailoiu GC; Brailoiu E; Benamar K; Abood ME
Mol Pharmacol; 2015 Aug; 88(2):265-72. PubMed ID: 25972448
[TBL] [Abstract][Full Text] [Related]
2. GPR55-mediated effects on brain microvascular endothelial cells and the blood-brain barrier.
Leo LM; Familusi B; Hoang M; Smith R; Lindenau K; Sporici KT; Brailoiu E; Abood ME; Brailoiu GC
Neuroscience; 2019 Aug; 414():88-98. PubMed ID: 31279825
[TBL] [Abstract][Full Text] [Related]
3. Differential activation of cultured neonatal cardiomyocytes by plasmalemmal versus intracellular G protein-coupled receptor 55.
Yu J; Deliu E; Zhang XQ; Hoffman NE; Carter RL; Grisanti LA; Brailoiu GC; Madesh M; Cheung JY; Force T; Abood ME; Koch WJ; Tilley DG; Brailoiu E
J Biol Chem; 2013 Aug; 288(31):22481-92. PubMed ID: 23814062
[TBL] [Abstract][Full Text] [Related]
4. GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.
Bondarenko A; Waldeck-Weiermair M; Naghdi S; Poteser M; Malli R; Graier WF
Br J Pharmacol; 2010 Sep; 161(2):308-20. PubMed ID: 20735417
[TBL] [Abstract][Full Text] [Related]
5. The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells.
AlSuleimani YM; Hiley CR
Br J Pharmacol; 2015 Jun; 172(12):3043-57. PubMed ID: 25652040
[TBL] [Abstract][Full Text] [Related]
6. Blockade of GPR55 in dorsal periaqueductal gray produces anxiety-like behaviors and evocates defensive aggressive responses in alcohol-pre-exposed rats.
Vázquez-León P; Miranda-Páez A; Calvillo-Robledo A; Marichal-Cancino BA
Neurosci Lett; 2021 Nov; 764():136218. PubMed ID: 34487839
[TBL] [Abstract][Full Text] [Related]
7. A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity.
Hurst K; Badgley C; Ellsworth T; Bell S; Friend L; Prince B; Welch J; Cowan Z; Williamson R; Lyon C; Anderson B; Poole B; Christensen M; McNeil M; Call J; Edwards JG
Hippocampus; 2017 Sep; 27(9):985-998. PubMed ID: 28653801
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells.
Obara Y; Ueno S; Yanagihata Y; Nakahata N
PLoS One; 2011; 6(8):e24284. PubMed ID: 21904624
[TBL] [Abstract][Full Text] [Related]
9. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?
Nevalainen T; Irving AJ
Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712
[TBL] [Abstract][Full Text] [Related]
10. GPR55 in the brain and chronic neuropathic pain.
Armin S; Muenster S; Abood M; Benamar K
Behav Brain Res; 2021 May; 406():113248. PubMed ID: 33745983
[TBL] [Abstract][Full Text] [Related]
11. GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans.
Liu B; Song S; Ruz-Maldonado I; Pingitore A; Huang GC; Baker D; Jones PM; Persaud SJ
Diabetes Obes Metab; 2016 Dec; 18(12):1263-1273. PubMed ID: 27561953
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells.
Harada K; Kitaguchi T; Kamiya T; Aung KH; Nakamura K; Ohta K; Tsuboi T
J Biol Chem; 2017 Jun; 292(26):10855-10864. PubMed ID: 28533434
[TBL] [Abstract][Full Text] [Related]
13. Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning.
Mosca MG; Mangini M; Cioffi S; Barba P; Mariggiò S
Cell Commun Signal; 2021 Apr; 19(1):48. PubMed ID: 33902596
[TBL] [Abstract][Full Text] [Related]
14. l-α-Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK-dependent pathway.
Robertson-Gray OJ; Walsh SK; Ryberg E; Jönsson-Rylander AC; Lipina C; Wainwright CL
Pharmacol Res Perspect; 2019 Jun; 7(3):e00487. PubMed ID: 31149342
[TBL] [Abstract][Full Text] [Related]
15. Contribution of G Protein-Coupled Receptor 55 to Periaqueductal Gray-Mediated Antinociception in the Inflammatory Pain.
Blanton H; Armin S; Muenster S; Abood M; Benamar K
Cannabis Cannabinoid Res; 2022 Jun; 7(3):274-278. PubMed ID: 35612493
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin excites periaqueductal gray neurons projecting to the rostral ventromedial medulla.
Li AH; Hwang HM; Tan PP; Wu T; Wang HL
J Neurophysiol; 2001 Apr; 85(4):1479-88. PubMed ID: 11287471
[TBL] [Abstract][Full Text] [Related]
17. The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion.
Kallendrusch S; Kremzow S; Nowicki M; Grabiec U; Winkelmann R; Benz A; Kraft R; Bechmann I; Dehghani F; Koch M
Glia; 2013 Nov; 61(11):1822-31. PubMed ID: 24038453
[TBL] [Abstract][Full Text] [Related]
18. The GPR55 agonist lysophosphatidylinositol acts as an intracellular messenger and bidirectionally modulates Ca2+ -activated large-conductance K+ channels in endothelial cells.
Bondarenko AI; Malli R; Graier WF
Pflugers Arch; 2011 Jan; 461(1):177-89. PubMed ID: 21072666
[TBL] [Abstract][Full Text] [Related]
19. Role of GPR55 during Axon Growth and Target Innervation.
Cherif H; Argaw A; Cécyre B; Bouchard A; Gagnon J; Javadi P; Desgent S; Mackie K; Bouchard JF
eNeuro; 2015; 2(5):. PubMed ID: 26730399
[TBL] [Abstract][Full Text] [Related]
20. GPR55 agonist lysophosphatidylinositol and lysophosphatidylcholine inhibit endothelial cell hyperpolarization via GPR-independent suppression of Na
Bondarenko AI; Montecucco F; Panasiuk O; Sagach V; Sidoryak N; Brandt KJ; Mach F
Vascul Pharmacol; 2017 Feb; 89():39-48. PubMed ID: 28064014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
